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Abstract
Background: Disclosure of Human Immunodeficiency Virus (HIV) to infected older children and adolescents is
essential for both personal health maintenance and HIV prevention within the larger population. Non-disclosure of
HIV status has been identified as one of the potential barriers to optimum adherence especially in children and
adolescents. Like many other countries in the SSA region, Ghana has significant number of children and
adolescents infected by HIV, who have increased survival times, due to increased access to ART. However, both
family caregivers and healthcare workers face an array of challenges with the disclosure process, including the
timing, what information about the child’s HIV status should be shared with him/her and how to go about it. The
aim of the study was to identify family caregiver factors associated with non-disclosure of HIV status to infected
children and adolescents accessing Antiretroviral Therapy (ART) at the three main ART sites within the Central
Region of Ghana.
Methods: A quantitative analytical survey was conducted among 103 family caregivers of HIV infected children
(aged 6–17 years) assessing ART services in the Central Region of Ghana. Data were analyzed using SSPS version 21.
Results: The age range of caregivers was 20–69 years. The study found a low disclosure rate (23.3%) among
caregivers. Majority of the caregivers (80.6%) lacked knowledge on the process of disclosure (how and what to tell
child), and majority (64%) also had never received guidance about the disclosure process from their healthcare
providers. The main barriers to disclosure were caregiver lack of knowledge regarding the disclosure process and
when to disclose, the fear of child’s reaction, and fear of stigmatization and associated negative social
consequences.
Conclusion: These findings suggest a lesser involvement of health care providers in preparing caregivers for the
disclosure process. This therefore highlight the need for the National HIV/AIDS/STI Control Program to strengthen
the involvement and training of healthcare providers in HIV diagnosis disclosure to infected children, based on
context-specific policy guidelines informed by the WHO recommendations.
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Background
Disclosure of Human Immunodeficiency Virus (HIV)
diagnosis to infected children is an important issue in
clinical practice in recent times, because it presents
with many clinical and psychosocial benefits that seek
to improve the quality of life of people infected and
affected by the HIV disease [1]. In the context of
paediatric HIV, disclosure refers to a child gaining
knowledge of his/her HIV status [2]. The American
Academy of Paediatrics Committee (AAPC) and the
WHO strongly recommend the disclosure of HIV
diagnosis to older children of school age and beyond,
on ethical and clinical grounds. Recognizing the im-
portance in improved quality of long-term care for
this vulnerable population, the WHO recommends
that children of school age should be told their HIV
positive status and that younger children should be
told their status incrementally to accommodate their
cognitive skills and emotional maturity, in preparation
for full disclosure [3, 4].
Evidence from studies conducted in resourced coun-
tries, shows that informing children about their HIV
diagnosis can have positive psychosocial and clinical out-
comes. These include improved adherence with associ-
ated increased survival rates, improved personal health
maintenance, decreased psychological effects associated
with accidental disclosure and improved HIV prevention
within the larger population [4–9]. Effective disclosure is
so important because it is a start in meeting the
often-repetitive education needs of HIV young people,
around daily living with the virus and how it will influ-
ence decisions that they make in their social lives; in-
cluding managing their own health, disclosing to
significant others, and sexual choices [3, 5, 6, 10, 11].
UNESCO’s strategy for HIV and AIDS also reported that
as these children grow older into adolescents, the know-
ledge about their disease will enable them make safe and
healthy life choices about relationships, sex, and
reproduction [5].
Several studies have evidently shown that children
who are fully disclosed to, become self-motivated and
are more likely to adhere to Antiretroviral Therapy
(ART) and overcome external adherence challenges [6–
9]. The success of ART leads to dramatic changes in
the clinical course of HIV infection in paediatric pa-
tients and consequently increases their survival time.
For ART to be successful, sustained and optimum ad-
herence is required. On the other hand, non-disclosure
of HIV status has been identified as one of the potential
barriers to optimum adherence especially in children
and adolescents [6, 12, 13]. Non-disclosure is linked to
poor adherence, which would lead to treatment failure,
increased viral load, increased risk of early disease pro-
gression or dramatic changes in the clinical course of
HIV infection, and consequently decreased survival time of
these young people. Also, if infected youth are non-adherent,
they could potentially transmit drug-resistant virus to their
sexual partners through unprotected sex, thereby increasing
HIV spread [10–12].
In the early part of the epidemic, especially in the
sub-Saharan Africa (SSA) where access to ART was lim-
ited, HIV/AIDS increasingly affected the health and wel-
fare of infected children with more deaths recorded [3,
14]. Due to the very low survival rate, few providers were
concerned about disclosing the diagnosis to these children
[3]. However, the increased access to ART and its success
in the treatment of paediatric HIV in recent times, has
changed the face of the HIV epidemic in children, in such
resource limited settings, and most children live longer
than before [3, 15, 16]. This has therefore called for a
change in the practice of non-disclosure and more care-
givers must therefore be prepared to disclose to their in-
fected children [10]. Contrary to this expectation, several
studies have shown that the increased survival times has
rather presented with one of the biggest psychosocial chal-
lenges that family caregivers face with regards to the dis-
closure of HIV diagnosis to their infected children [2, 13,
17, 18]. As such, more caregivers are hesitant or unable to
disclose and many might choose to withhold an HIV diag-
nosis throughout the HIV-infected child’s life [1]. Re-
searchers on the subject agree that the caregivers’
reluctance to disclose is especially so in the developing
countries and that not only family caregivers are reluctant
or find it difficult to disclose but healthcare workers as
well [8, 9, 19, 20].
The disclosure situation is not different in Ghana.
Enforcing adherence has resulted in confrontations
and conflicts with caregivers since the caregivers are
unwilling to explain to their infected children why
they are on medications. Regardless of the hindrances
to good adherence and improved self-care, some par-
ents still have strong reservations for disclosure of
status to their adolescent children, although their rea-
sons are not well articulated [21]. Like many other
countries in the SSA region, Ghana has significant
number of children and adolescents infected by HIV,
who have increase in survival times, due to increased
access to ART [22]. Although the provision of ART is
about a decade now, limited policy research on dis-
closure of HIV diagnosis to children has been carried
out in the country.
This non-disclosure if allowed to continue would have
negative ramifications for not only the affected adolescents,
but the entire nation. This is because non-disclosure will
lead to non-adherent and consequently poor treatment out-
come such as treatment failures, increased drug resistance
strains, increased viral load, and associated risk of HIV
transmission to the general population [10–12].
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It is for these reasons that understanding the influen-
cing factors of disclosure of HIV status to infected
children, is to be viewed as increasingly important in the
management and care of HIV infected children. The
study therefore sought to evaluate family caregiver
factors that hinder the disclosure of HIV diagnosis to
children in the Central Region of Ghana. The results of
this study are critical in adding new knowledge that will
facilitate training guidelines for health personnel curric-
ula, directed at how the process of disclosure should be
instituted. The findings of the study will also help bridge
the existing gap in the literature about disclosure of HIV
diagnosis to children in resourced limited settings.
Methods
Study site and population
A total of 103 family caregivers of children and adoles-
cents aged 6–17 years on ART, who accompanied their
children to assess HIV services at the three main ART
sites within the Central Region, were sampled and in-
cluded in the study. Literature suggests that the best age
to disclose to a child is 6 years and above because at that
age the child was able to understand disease and illness
[2]. The definition of a child according to the children’s
ACT 560, is a person below 18 years. The age group of
children used in the study is based on these reasons.
The sites were: the Cape Coast Teaching Hospital, Cape
Coast; St. Francis Xavier Catholic Hospital, Assin Fosu;
and the Winneba Government Hospital, Winneba. These
facilities offer both general medical care and antiretroviral
treatment (ART) for all age groups including children and
adolescents in the Central Region of Ghana.
A total of 110 registered dyads of caregiver and child
that fell within the inclusion criteria were used. Out of
the total number of the 110 registered dyads, six (6)
were used as pilot and were not included in the main
study; one (1) registered dyad had moved out of the re-
gion and could not be traced. Data were collected from
the remaining 103. Fifty-eight (58) of the respondents
were recruited from the Cape Coast Teaching Hospital,
23 from St. Francis Xavier Hospital, and 29 from the
Winneba Government Hospital. Caregivers were re-
cruited to participate as they waited for consultation and
medication during their routine monthly visits for ART
for their children.
Study design and data collection procedure
A descriptive quantitative survey was conducted using a
structured interviewer administered questionnaire. The
validity and reliability of the data collection tools and
procedures were also determined; Cronbach alpha was
calculated as a measure of internal consistency for the
total instrument and was found to have high internal
consistency; Alpha co-efficients for the subscales ranged
from 0.848 to 1.000. Data were collected between Janu-
ary and April, 2014. Two weeks prior to the main study
a pilot study was conducted with six (6) caregivers of
children on ART (2 each) from the study settings. Data
collection was conducted during clinic attendance by the
researcher and trained research assistants, who were all
professional HIV counselors.
Validity and reliability of the instrument
The validity and reliability of the data collection tools and
procedures were determined; Cronbach alpha was calcu-
lated as a measure of internal consistency for the final in-
strument; the total instrument was found to have high
internal consistency, with an alpha coefficient of 0.978
(Table 1). Alpha coefficients for the subscales ranged from
0.848 to 1.000. The scale used in assessing the knowledge
had seven items and the Cronbach’s reliability coefficient
alpha for this scale was 0.848. The scale used in assessing
caregiver reasons for delayed disclosure had 10 items and
the Cronbach’s reliability coefficient alpha for this scale was
1.000. The scale used in assessing non-disclosed caregiver
reasons for non-disclosure had 21 items and the Cronbach’s
reliability coefficient alpha for this scale was 1.000.
Data analysis
Data were cleaned, coded and captured on Microsoft
Excel and analyzed using statistical packaging for social
sciences (SPSS) software version 21. Summary statistics
was used to calculate and interpret the mean, and range of
continuous variables under investigation and to obtain fre-
quency tables for discrete variables. The data was pre-
sented through tables and frequency distributions.
Inferential statistics, specifically factor analysis was also
performed on the non-disclosed caregivers reasons for
non- disclosure, to determine the most important factors
that hindered the disclosure process.
Ethical considerations
The University of Cape Coast institutional project review
board (UCCIRB) granted ethical approval for the study be-
fore commencement. Clearance was also given by the
NACP/GHS, after signing a data sharing agreement.
Permission was also gained from management of the three
hospitals, where the study was conducted. Confidentiality
was ensured at all stages of the process. Data collection was
preceded by an informed consent signed by participants.
Results
Data were collected from a total of = 103 of disclosed
and non-disclosed caregivers of children aged between 6
and 17 years. All completed the questionnaire ad-
equately making the response rate 100%. As shown in
Table 1, the caregivers aged between 20 and 69 years
with a mean age of 42 years. The highest proportions of
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the caregivers were females and the biological mothers
of the children (n = 85, 82.5%) and (n = 50, 48.6%), re-
spectively. Biological fathers constituted less than a tenth
(n = 9, 8.7%) More than half (n = 56, 54.4%) of the care-
givers were HIV positive and almost one fifth (n = 19,
18.4%) did not know their HIV status. The highest pro-
portion (n = 44, 42.7%) were married. With regards to
their educational attainment, the majority (n = 60,
58.3%) comprised those with either no formal education
or had up to primary level, and less than a tenth 9 (8.7%)
had completed tertiary education. The majority (n = 75,
72.8%) also reported being financially independent.
Comparing the disclosed and non-disclosed groups, less
than a tenth (n = 9, 8. 8%), of the 50 biological mothers
interviewed had disclosed to their children as against the
greater proportion (n = 41, 39.8%) who had not. The bio-
logical mothers also constituted greatest proportion (n = 41,
39.8%) out of the total 79 non-disclosed caregiver category.
Table 1 Caregiver Characteristics by their Children’s HIV Disclosure Status (N = 103)
VARIABLE Total n (%) Disclosure rate
Disclosed =24
(23.3%) (n %)
Not-disclosed = 79
(76.7) (n/%)
Gender of caregiver
Male 18 (17.5) 8 (7.8) 10 (9.8)
Female 85 (82.5) 16 (15.5) 69 (67.5)
Age of caregiver (yrs.)
20–39 44 (42.7) 7 (6.8) 37 (36.3)
40–59 48 (46.6) 7 (6.8) 41 (40.3)
60–69 11 (10.7) 10 (9.7 1 (0.1)
Marital status
Married or cohabiting 46 (44.6) 9 (8.8) 37 (36.3)
Single 18 (17.5) 7 (6.8) 11 (10.8)
Divorced/separated/ widowed 39 (37.9) 8 (7.8) 31 (29.6)
Relation to child
Biological mother 50 (48.5) 9 (8.8) 41 (39.8)
Biological father 9 (8.7) 3 (2.9) 6 (5.8)
Grandparents 19 (18.5) 7 (6.8) 12 (11.7)
Uncle or aunt/ 20 (19.4) 5 (4.8) 15 (14.6)
Foster parents 3 (2.9) 0 3 (2.9)
Siblings 2 (1.9) 0 2 (1.9)
Financial situation
Independent 75 (72.8) 22 (21.4) 53 (51.5)
Dependent 28 (27.3) 2 (1.9) 26 (25.2)
Level of education
No formal education 24 (23.3) 3 (2.9) 21 (20.4)
Up to primary level 36 (34.9) 6 (5.8) 30 (29.1)
Up to secondary school level 34 (33.1) 8 (7.8) 26 (25.2)
Up to tertiary level 9 (8.7) 7 (6.8) 2 (1.9)
HIV status of caregiver
Positive 56 (54.4) 13 (12.6) 42 (40. 8)
Negative 28 (27.2) 7 (6.8) 21 (20.4)
Don’t know 19 (18.4) 4 (3.9) 16 (15.5)
Child’s age at disclosure
6–10 49 (47.6) 1 (1.0) 48 (46.5)
11–14 40 (38.8) 9 (8.7) 31 (30.1)
> 14 14 (13.6) 14 (13.6) 0 (0)
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Also, majority (n = 42, 40.8%) of the non-disclosed care-
givers were HIV positive themselves. It is noteworthy that,
a small proportion (n = 2, 1.9%) of caregivers who had
attained tertiary education had not disclosed as compared
to highest proportion (n = 51, 49.5%) of those with primary
or no educational background.
Table 2 presents the disclosed caregivers disclosure
related experiences. Majority (n = 16, 66.7%) were able
to disclose with the support of their healthcare pro-
viders with only a third (n = 8, 33.3%) being able to
do so by themselves. Interestingly, only a quarter
were able to disclose confidently. Regarding the time
frame for disclosure after child’s diagnosis, only a fifth
(n = 5, 20.8%) out of the 24 caregivers who have dis-
closed to their children were able to disclose within a
year. It took the majority (n = 10, 41.7%) between 1
and 5 years, and more than a quarter (n = 9, 37.5%)
after 5 years. Disclosed caregivers reported that they
delayed the disclosure for various reasons. For the
disclosed group, the main reasons for the disclosure
were child being of age and pubertal age (n = 69,
87.3%) and support from healthcare providers (n = 59,
74.7%). More than half (n = 57, 72.2%) and (n = 56,
70.9%) respectively, had to disclose because their chil-
dren were becoming increasingly curious about their
daily medications and their routine clinic attendance.
The level of knowledge of the respondents regarding
the definition, benefits and the process of HIV diagnosis
disclosure to an infected child were assessed and the
data presented in Fig 1. Each item had more than one
expected response and participants who were able to
score more than half (50%), were graded knowledgeable,
whilst those who scored less than 50% were graded as
lacking knowledge. The expected responses were gener-
ated from the WHO guideline for disclosing the HIV
diagnosis to infected children. The Cronbach’s reliability
coefficient alpha for this 7 items scale was 0.848.
All caregivers (n = 103, 100%) could define HIV diagno-
sis disclosure and majority (n = 56, 54.4%) had knowledge
about the appropriate places where disclosure can take
place. Majority (n = 69, 67.0%) were also knowledgeable
about the benefits or importance of disclosure. On the
other hand, more than 50% of the respondents lacked
knowledge regarding persons considered appropriate to
disclose and appropriate child’s age of disclosure process.
Concerning appropriate timing for the disclosure more
than two thirds (n = 70, 68.0%) lacked knowledge. What
and how to tell child was the biggest hindrance of which
(n = 83, 80.6%) lacked knowledge.
To help give better explanations to the outcome of the
knowledge level assessment, caregivers were also asked
if they had received any form of counseling or guidance
as to how to disclose. Out of the 103 respondents, only
about a third (n = 35, 34.0%) had been taught by their
healthcare providers regarding how to disclose the HIV
diagnosis to their infected children, whilst the majority
(66.0%) had not been taught how to do so. The other 2
(1.9%) of the caregivers also learned how to disclose
from their peer educators.
Caregiver barriers towards HIV diagnosis disclosure to
their infected children
Caregivers completed a survey focused on reasons for
delayed or non-disclosure. Although there are some
caregivers who have disclosed, as described above, most
of them delayed disclosure. Two barrier scales were used
respectively for the caregivers who delayed disclosure
and those who have not disclosed. Scale 1 contained 10
items (Table 3) whilst the main barrier scale comprised
21 items (Table 5).
Disclosed caregivers’ reasons for delayed disclosure
Table 3 presents caregiver reasons for delaying in dis-
closing to their infected children and it revealed that
Table 2 Disclosed Child and Caregiver Disclosure Related
Experience (n = 24)
Variable n (%), Mean
Child’s Age at disclosure (years)
6–10 1 (4.2)
11–14 9 (37.5)
>14 14 (58.3)
Mean 10.4
Time frame of disclosure after child’s diagnosis
<1 year 5 (20.8%)
1–5 years 10 (41.7%)
> 5 years 9 (37.5%)
Caregiver supported by health provider in disclosing
Yes 16 (66.7)
No 8 (33.3)
Caregiver level of confidence at disclosing
Confident 6 (25.0)
Somehow confident 10 (41.7)
Not at all confident 8 (33.3)
Reasons for the disclosurea
Child has reached puberty and is of age 69 (87.3)
Child increasingly becoming curious
about daily medications
57 (72.2)
Child inquisitiveness about routine clinic
attendance
56 (70.9)
Child has started talking about sex and
sexual relationship
54 (68.4)
My healthcare provider asked me to
disclose and offered Support
59 (74.7)
amultiple responses
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more than 55% agreed to all the factors as reasons for
the delayed disclosure. The most important barriers to
timely disclosure identified in terms of ranking were;
fear of how child would react to the news of the diagno-
sis (95%), child not being old enough to understand
(90%), lack of caregiver readiness to discuss sex if child
ask how they got infected (90%), fear of child not being
able to keep diagnosis a secret and letting others know
(80%), and protecting child from HIV diagnosis related
stigma and discrimination (80%). A significant propor-
tion (n = 14, 70%) of caregivers also delayed the
disclosure because they did not know what and how to
tell child. Worthy of note, more than half (n = 11, 55%)
of the caregivers felt that disclosure to child at that age
would not have made any difference in child’s treat-
ment/care. This implies a significant number of the care-
givers believe that disclosure at a certain age, has some
impact on the child’s treatment or care.
Non-disclosed caregivers reasons for non-disclosure
For the non-disclosed caregiver reasons for non-disclosure,
a factor analysis was performed with a 21 items barrier
scale to identify and label the main caregiver barriers to dis-
closure. Principal component factor analysis of the 21
item-instrument was performed. After this had been ap-
plied, the new factors represented linear combinations of
variables with significant eigenvalues. Tables 4 and 5 re-
spectively, present the total variance explained and the bar-
riers hindering respondents, whilst Fig 2 is the scree plot of
the eigenvalues. The factor analysis yielded a seven-factor
solution with an explained variance of 68.6%, which had ei-
genvalues greater than 1.00. Since all seven (7) factors had
eigenvalues greater than 1, the final factor solution repre-
sented 68.6% of the variance in the data. According to the
scree plot (Fig 2), the slope of the curve became emergent
at the seventh point, as such a seven-factor instrument was
decided upon.
The remaining 14 items were entered into the factor
analysis. All items were loaded on expected factors, and
the variance was more than 0.45 for most items; with
only eight (8) below 0.4 (Table 5).
Table 5 shows the seven barriers to disclosure that
emerged in order of ranking. Of the seven factors, the
two most important identified were the lack of know-
ledge and fear of stigmatization. Those two factors had
Fig. 1 Caregivers level of knowledge regarding HIV diagnosis disclosure to HIV infected children (N = 103)
Table 3 Disclosed Caregivers Reasons for Delayed Disclosure
(N = 20)
Variable Agree, n (%)
I did not know how the child would react 19 (95.0)
The child was too young and not mature enough
to know
18 (90.0)
Disclosure to child at that age would not have
made any difference in child’s treatment/care
11 (55.0)
I did not know how to tell the child about this
diagnosis
14 (70.0)
I did not know what to tell child 14 (70.0)
I wanted to protect child from social stigma and
discrimination
16 (80.0)
I was afraid others would get to know if child fails
to keep the information secret
16 (80.0)
I was afraid disclosure would cause child to be
unhappy/depressed
15 (75.0)
I was afraid about child asking me how one
became infected, because child might blame me.
14 (70.0)
I could not have discussed sex with child at that
age if child asked me to explain how he/she
got infected.
18 (90.0)
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eigenvalues greater than 2 and had accounted for 24.74
and 11.13% of the total variation in the data, respect-
ively. This means that the two are the most disturbing
barriers. The remaining five items all had eigenvalues of
less than 2.00 but more than 1.00.
The strongest factor 1 as shown in Table 5 is lack of
knowledge on the disclosure process. Item loading on this
factor included five items: “my caregiver did not teach me
how to disclose”, “I do not know what and how to tell”, “I
do not know how child will react and how to handle any
negative reaction”, “I do not know the exact age at which
to tell the child.”, and “I do not know how to explain sex
to child if asked how he/she got infected”. Item loading on
the next disturbing factor, fear of stigma also included four
items: “I do not know how my religious members will
think about me”, “I may lose my job if through child
others get to know”, “I am afraid to lose my social status”,
and “I have witnessed families who face stigma and dis-
crimination because they disclosed. I don’t want my family
to go through that stress.”
The highest of the remaining five factors is caregiver
fear of hurting/harming child, which had three specific
item loading: “Protect the child from depressing infor-
mation. The child deserves a happy childhood”, “fear of
rejection by the child”, and “afraid the child might not
be able to keep the diagnosis a secret which may lead to
such as social rejection”. The lowest of the factors was
that of untimeliness and the specific item loading in-
clude two items; “child is too young to know” and “dis-
closing to children before their teen years will not make
any difference to the child”.
Discussion
The study revealed that a greater proportion (n = 79,
76.7%) of the children had not been told of their HIV
diagnosis by their caregivers. These findings are consistent
with those from other studies [13, 19–21, 23]. Although
the documented prevalence of disclosure of HIV diagnosis
to infected in children from well-resourced countries vary
widely, from 18 to 77% [2, 23], in resource limited coun-
tries the prevalence remains low. Data from a previous
Ghanaian study and two South African studies reported
low levels of disclosure of HIV diagnosis to children on
antiretroviral therapy [13, 23, 24]. In a cross-sectional
study on the prevalence and determinants of disclosure
among caregiver-child dyads from the Pediatric HIV/
AIDS Care Program at Korle-Bu Teaching Hospital (Accra,
Ghana), Kallem and colleagues reported prevalence of 21%
[13]. In addition, clinical observation with HIV-positive
children at three paediatric HIV clinics in a tertiary hospital
in Johannesburg suggested that disclosure of HIV status
rarely occurs [23]. Similar observation has been made in
one of the largest ART sites in Ghana, the Komfo Anokye
Teaching Hospital [21].
More than half (54.4%) of the caregivers were HIV posi-
tive with less than a fifth (18.4%) who did not know their
HIV status and less than a tenth (n = 9, 8. 8%), of the 50
biological mothers interviewed had disclosed to their chil-
dren whilst biological mothers constituted greatest pro-
portion (n = 41, 39.8%) of the total non-disclosed caregiver
category. It is worth noting that, majority (n = 42, 40.8%)
of the non-disclosed caregivers were HIV positive them-
selves. The findings confirmed what has been reported in
several other studies that parents’ own HIV status and fear
of being blamed by the child can influence their
decision-making regarding disclosure of the child’s HIV
status as well as their ability to disclose [10, 13, 25, 26].
One plausible reason given to this disclosure pattern is
that most of HIV positive parents feel guilty and respon-
sible for infecting the children and therefore, failed to dis-
close in order to protect themselves from their child’s
reaction, anger or blame on learning about the caregivers’
own HIV diagnosis [8, 9, 19, 20]. Furthermore, due to the
stigma associated with the disease as well as the sexual
mode of transmission, disclosure has been shown to be
most difficult, especially, for biological parents who might
Table 4 Total Variance Explained for Barriers to the Disclosure Process
Component Initial Eigenvalues Extraction Sums of Squared Loadings
Total % of Variance Cumula-tive % Total % of Variance Cumula-tive %
1. Caregiver lack of knowledge 5.196 24.745 24.745 5.196 24.745 24.745
2. Caregiver fear of stigmatization 2.338 11.132 35.877 2.338 11.132 35.877
3. Protection of child from hurt and
social rejection
1.795 8.546 44.422 1.795 8.546 44.422
4. Discouragement from family, friends,
and previous disclosure attempts
1.515 7.217 51.639 1.515 7.217 51.639
5. Fear of losing family 1.268 6.038 57.677 1.268 6.038 57.677
6. Fear of child’s reaction to the
diagnosis
1.234 5.876 63.553 1.234 5.876 63.553
7. Untimeliness in terms of child’s
age or maturity.
1.050 5.002 68.555 1.050 5.002 68.555
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be particularly worried about their children learning of
their illness [15, 17, 19, 20, 27]. It is therefore not surpris-
ing that, caregivers who disclosed early tend to be
non-biological parents of the infected children and likewise
most children who knew their diagnosis were those living
with non-biological caregivers [13, 15, 20]. Another obser-
vation made from this study is that, although a small
proportion, majority of caregivers who had attained tertiary
education had disclosed as compared to those with primary
or no educational background. Possibly, this is because,
the educated feel more equipped to handle the disclos-
ure process than the uneducated. Although similar
studies conducted in Ethiopia, Thailand and South
Africa, have cited caregiver educational background as
Table 5 Caregivers barrier to the disclosure process
Barriers
Lack of
Education
Fear of
stigmatization
Fear of hurting
child
Discouragement Disrupting child’s
education
Fear of
divorce
Untimeliness
My care provider did not teach me
how/what to tell child
0.807
I do not know the exact age to
disclose
0.723
I don’t know how child will react and
how to manage such reactions
0.645
I feel guilty/ashamed for transmitting
the infection
0.635
I do not know how to explain sex to
child if asked how he/she got infected
0.498
I don’t know how my religious
members will think of me
0.768
I may lose my job if others get to
know through my child
0.733
I am afraid to lose my social status 0.699
I have witnessed families who face
stigma and discrimination because
they disclosed.
0.628
Protect the child from depressing
information.
0.777
Fear of rejection by the child 0.727
I am afraid the child might not be
able to keep the diagnosis a secret
leading to social rejection
0.657
My family discouraged me from
disclosing
0.778
In the past I tried to disclose but
I failed
0.706
My friends discouraged me from
disclosing
0.572
My in-laws will distrust me and I
will lose my marriage if through
child others get to know
0.842
My family will disown me should
they hear of my child’s diagnosis
0.642
Disclosure will cause lack of
concentration in school
0.779
Disclosure will decrease child’s
quality of life
0.456
Child is too young to know or
understand
0.753
Disclosing to children before
their teen years will not make
any difference to the child
0.535
Hayfron-Benjamin et al. BMC Pediatrics          (2018) 18:365 Page 8 of 11
a correlate of disclosure to HIV-infected children, our
findings are contrary to theirs. Those studies reported a
higher rate of disclosure among caregivers with a lower
level of education [19, 28].
Low disclosure rates in this study could also be attrib-
uted to family caregiver lack of disclosure related know-
ledge and skills as well as the low involvement of health
care providers in disclosing the HIV diagnosis to their
infected children. Caregiver knowledge assessment re-
garding the disclosure process showed that all (100%)
caregivers in this current study were aware of the con-
cept HIV diagnosis disclosure and knew that at a point
in the child’s life they needed to disclose the HIV diag-
nosis to the child. Although generally, majority (67.0%)
had good knowledge about the importance of disclosure,
it is worth noting that majority lacked knowledge about
the disclosure related process: Greater proportion
(80.6%) of the caregivers lacked knowledge about what
to tell child and how to go about it. Majority (more than
50%) also lacked knowledge about the appropriate per-
son to disclose to child, appropriate timing, and appro-
priate child’s age, for the disclosure.
Caregiver lack of knowledge could be attributed to the
poor preparation and lack of teaching by their respective
healthcare providers. In our study, about two thirds
(66%) of the caregivers, had not been taught or received
any guidance on how to disclose to their children. The
poor preparation could also explain why only a small
proportion (25%) of the disclosed caregivers was re-
ported of being confident at disclosing and also why a
greater proportion (66.7%) were only able to disclose
with the support of a healthcare provider. This data was
comparable with findings from previous studies which
indicated that low levels of direct involvement of health
care professionals in disclosure process was associated
with low prevalence of disclosure among family care-
givers [19, 23, 29]. The findings suggest that health care
providers played a major role in initiating disclosure
with children in clinical settings.
From the above findings and discussions, it is there-
fore not surprising that, caregiver’s lack of knowledge
on the process of disclosure was the most distinct
barrier identified in this study, Specifically, caregivers
lacked knowledge about when, how and what to tell
the child, how to explain the infectious process to the
child, and how to manage any negative child reaction
with regards to the disclosure. A number of studies
have reported family caregivers’ lack of knowledge re-
garding the appropriate age, timing, and what to tell
as being linked to the delay in diagnosis disclosure to
infected children [6, 24, 26, 30].
Caregiver fear of disclosure associated stigmatization
and consequences such as social rejection were the sec-
ond highest ranking barrier identified in this study. This
was closely followed by caregiver fear of child being hurt
or harmed as a consequence of negative social reaction
towards a positive HIV status. The four other significant
barriers identified namely; untimeliness with regards to
child’s age; discouragement from family members,
friends, and previous disclosure related negative experi-
ence; fear of divorce; and interrupting child education,
were observed to be all closely linked to caregivers’ fear
of negative social consequences associated with stigma
and discrimination, should the child fail to keep the
diagnosis a secret and others get to know about child’s
HIV status. Protecting the child from the stigma associ-
ated with HIV has been documented as one of the major
reasons for non-disclosure of HIV diagnosis to children
Fig. 2 Scree plot for factor analysis of the barriers to disclosure
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[23, 25, 31, 32]. Other studies reported that caregivers
often delayed the disclosure because of caregiver fears
that the younger child would tell others and face
discrimination.
This study also found untimeliness with regards to
child’s age as one of the barriers. Majority of caregivers
in this current study, delayed disclosure because they be-
lieved that the child was too young or immature to
understand the disease. The findings are similar to those
reported in other studies [6, 24, 25, 27, 32]. Child’s age is
also closely linked to ability or inability to keep the diag-
nosis a secret, and over the years this keeps appearing in
studies on disclosure of HIV diagnosis to children. Care-
givers are reluctant to disclose the HIV diagnosis to their
younger children because they perceived that at that
young age, children lack the emotional and cognitive
maturity needed to fully comprehend the disease and its
implications, or to cope with the diagnosis [6, 18, 32].
This barrier could explain why in this current study,
majority (n = 79, 76.7%) of the children had not been told
of their HIV diagnosis, and why almost all (99%) of the 49
children that were below 10 years of age had not been dis-
closed to, whereas all of those above 14 years had been
disclosed to. The disclosure related age distribution pat-
tern implies that children below 10 years were least likely
to be disclosed to as compared to those above 14 years.
These findings are congruent with results from other
studies from various parts of the world. Majority of care-
givers in those studies felt that the child should be told
about their HIV diagnosis around 14 years. Caregivers are
more likely to disclose the HIV diagnosis to children over
13 years for varied reasons. The main reason identified are
that older children have emotional maturity and intellec-
tual capacityand are considered mature enough to cope
with the news of their HIV status, and are also able to
understand concepts of health, disease, and more complex
concepts of chronic illness. Also, its because sex education
and prevention of the spread of infection may require dis-
closure [11, 19, 23–25, 32].
The study’s main limitation was in terms of the
generalizability of its results. All participants were re-
cruited from the Central Region of Ghana, as such, the
study cannot be generalized to caregivers outside the
Central Region of Ghana, due to differences in cultural
practices. Further studies are therefore needed to deter-
mine whether the findings are representative of the situ-
ation in other areas of Ghana.
Conclusion
This study reiterates the findings of other studies from
the SSA region that caregiver lack of knowledge regard-
ing the disclosure process greatly hinders timely disclos-
ure of the HIV diagnosis to infected children. The fear
of stigma and associated negative social consequences
such as, social rejection and loss of social status also
greatly influenced the disclosure process. Stigma and
discrimination remain a threat to timely disclosure and
if not well addressed, the nation would be faced with
majority of adolescents who are not disclosed to. This
could result in associated negative consequences such as
non-adherence to treatment, increased viral load, and in-
creased risk of HIV transmission among the youth.
There is therefore the need for healthcare providers and
other stakeholders to continue relentlessly in the cam-
paign against HIV related stigma and discrimination.
The findings also suggest a lesser involvement of health
care providers in preparing the caregivers for the disclos-
ure process, indicating weaknesses in the psychosocial as-
pect of HIV management of children and adolescents.
The findings highlight the need for the NACP to
strengthen healthcare providers’ involvement in HIV dis-
closure to children and adolescents. This would require
development of context-specific policy guidelines in-
formed by the WHO recommendations on disclosure to
children and adolescents. Such guideline will serve as a
resource for healthcare providers to provide standardized
training to the family caregivers. Further studies are re-
quired to explore healthcare provider’s knowledge, atti-
tude, and practices of the disclosure process. This would
help identify gaps in the healthcare system and inform
policy makers and stakeholders on how to tackle the
problem.
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